According to Wei et al. [27], these tumours represent an aggressive variant, while others maintain that their behaviour does not vary from that of invasive carcinoma NST in relation to grade, stage and expression of estrogen and progesterone receptors (ER and PgR) [2, 4, 6]. The gene discussed is PGR; the disease is neoplasm.